PureTech Health (PRTC)

Sector:

Pharma and Biotech

Index:

FTSE Small Cap

132.40p
   
  • Change Today:
      0.40p
  • 52 Week High: 150.20
  • 52 Week Low: 103.00
  • Currency: UK Pounds
  • Shares Issued: 241.68m
  • Volume: 453,307
  • Market Cap: £319.99m
  • Beta: 0.91

PRTC Overview

PureTech Health plc (“PureTech Health”, “PureTech” or “the Company”) is a clinical-stage biotherapeutics company dedicated to discovering, developing and commercializing highly differentiated medicines for devastating diseases, including inflammatory, fibrotic and immunological conditions, intractable cancers, lymphatic and gastrointestinal diseases and neurological and neuropsychological disorders, among others.

Key Personnel

CEO: Robert Lyne
Independent Non-Executive Director: John LaMattina
Independent Non-Executive Director: Michele Holcomb
Independent Non-Executive Director: Kiran Mazumdar Shaw
Interim Chairman: Sharon Barber-Lui
Non-Executive Dir: H. Robert Horvitz, Robert Langer

Contact Details

Address: 6 Tide St Ste 400, Boston, United States, MA, 02210
Phone: +1 617 482 2333
Website: http://www.puretechhealth.com

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE Small Cap, FTSE All-Share
Overseas Listings: BATSLON:PRTCL
ISIN: GB00BY2Z0H74

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

PRTC Market Data

Currency UK Pounds
Share Price 132.40p
Change Today 0.40p
% Change 0.30 %
52 Week High 150.20
52 Week Low 103.00
Volume 453,307
Shares Issued 241.68m
Market Cap £319.99m
Beta 0.91

PRTC Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
49.17% above the market average49.17% above the market average49.17% above the market average49.17% above the market average49.17% above the market average
95.12% above the sector average95.12% above the sector average95.12% above the sector average95.12% above the sector average95.12% above the sector average
Price Trend
53.88% below the market average53.88% below the market average53.88% below the market average53.88% below the market average53.88% below the market average
Sector averageSector averageSector averageSector averageSector average
Income Not Available
Growth
23.61% below the market average23.61% below the market average23.61% below the market average23.61% below the market average23.61% below the market average
37.93% below the sector average37.93% below the sector average37.93% below the sector average37.93% below the sector average37.93% below the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

PRTC Dividends

No dividends found

Trades for 30-Jan-2026

Time Volume / Share Price
17:06 7,000 @ 132.40p
16:35 2 @ 132.40p
16:35 712 @ 132.40p
16:35 70,000 @ 132.56p
16:35 138,052 @ 132.40p

PRTC Key Personnel

CEO Robert Lyne

Top of Page